Literature DB >> 14651951

Evaluation of the neurorestorative effects of the murine beta-nerve growth factor infusions in old rat with cognitive deficit.

María R Castellanos1, Jorge Aguiar, Caridad Ivett Fernández, William Almaguer, Carmen Mejias, Alfredo Varela.   

Abstract

The nerve growth factor (NGF) is known to participate in the regulation of the expression levels and activity of the choline acetyltransferase (ChAT) in the nervous system. This enzyme is sensitive to the degenerative changes found in Alzheimer's disease (AD). We compared the effectiveness of intraparenchymal (ip) and intracerebroventricular (icv) administration of the murine beta-NGF (beta-NGFm) produced in our laboratories, through the determination of the expression levels and activity of the ChAT, and the evaluation of behavioral recovery in aged rat with cognitive deficit. Our results indicated that icv infusion of beta-NGFm stimulates the expression levels of ChAT gene in the striatum of old rats. Remarkable losses in the ChAT activity were observed in the septum and striatum of old rats. Exogenous administration of beta-NGFm produced a significant increase of ChAT activity in these brain regions differentially according to the administration pathway. The behavioral studies demonstrated that the administration pathway is an important factor in order to obtain the best results for a neurorestorative treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14651951     DOI: 10.1016/j.bbrc.2003.10.198

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

Review 1.  Neurotrophic factors and their effects in the treatment of multiple sclerosis.

Authors:  Shahnaz Razavi; Ghasemi Nazem; Mohammad Mardani; Ebrahim Esfandiari; Hossein Salehi; Sayyed Hamid Zarkesh Esfahani
Journal:  Adv Biomed Res       Date:  2015-02-17

2.  Recombinant COL6 α2 as a Self-Organization Factor That Triggers Orderly Nerve Regeneration Without Guidance Cues.

Authors:  Zhou Fang; Jian-Long Zou
Journal:  Front Cell Neurosci       Date:  2021-12-23       Impact factor: 5.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.